{
  "catalogId": "6aafe3ac-579a-4fe0-9303-cb663e08e15f",
  "name": "VYNDAMAX",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "166 51 36151 00",
  "treatmentDescriptions": "VYNDAMAX is indicated for the treatment of the cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular mortality and cardiovascular-related hospitalization.",
  "termsOfIssue": "Prescription required",
  "form": "capsules soft gelatin",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "TAFAMIDIS",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "N07XX08",
      "name": "TAFAMIDIS"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "VYNDAMAX 61 MG 30 CAPS",
      "manufacturer": {
        "name": "פיזר",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 30.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER ALUMINIUM /ALUMINIUM",
      "shelfLife": "24",
      "storageConditions": "",
      "codes": {
        "moh": "8550",
        "yarpa": "70767",
        "barcode": "7290013592767"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 40504.83918,
        "retailMargin": 10.0,
        "maxRetailPrice": 44555.3231,
        "maxPriceWithVAT": 52575.27892
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T22:09:12.465898"
  }
}